Effects of carrageenan and morphine on acute inflammation and pain in Lewis and Fischer rats

Brain, Behavior, and Immunity

Volumn 21, Issue 1, 2007, Pages 68-78

  Fecho, Karamarie ^a,b   Manning, Elizabeth L ^a   Maixner, William ^a,b   Schmitt, Charles P ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Copperline Solutions LLC ^*  (United States)

Author keywords

Allodynia; Analgesia; Carrageenan; Fischer 344; HPA axis; Hyperalgesia; Inflammation; Lewis; Morphine; Pain

Indexed keywords

CARRAGEENAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MORPHINE; MYELOPEROXIDASE; NITRIC OXIDE;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOCOMPATIBILITY TEST; HYPERALGESIA; INFLAMMATION; MALE; NEUTROPHIL; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CARRAGEENAN; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MALE; MORPHINE; NEUROIMMUNOMODULATION; PAIN; PAIN THRESHOLD; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED F344; RATS, INBRED LEW; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 33845192455     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.02.003     Document Type: Article

References (86)

1. Allen J.B., Calandra G.B., and Wilder R.L. Cutaneous inflammatory reactions to group A streptococcal cell wall fragments in Fisher and Lewis inbred rats. Infect. Immun. 42 (1983) 796-801
2. Blach-Olszewska Z. Innate immunity: cells, receptors, and signaling pathways. Arch. Immunol. Ther. Exp. 53 (2005) 245-253
3. Cano G., Arcaya J.L., Gómez G., Maixner W., and Suarez-Roca H. Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers. Neurochem. Res. 24 (1999) 1203-1207
4. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53 (1994) 55-63
5. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J. Immunol. 154 (1995) 4719-4725
6. Crain S.M., and Shen K.F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 88 (2001) 75-82
7. Cronstein B.N., Naime D., and Ostad E. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92 (1993) 2675-2682
8. Cunha F.Q., Lorenzetti B.B., Poole S., and Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104 (1991) 765-767
9. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107 (1992) 660-664
10. Cunha F.Q., Poole S., Lorenzetti B.B., Veiga F.H., and Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br. J. Pharmacol. 12 (1999) 45-50
11. Cunha F.Q., Verri Jr. W.A., Silva J.S., Poole S., Cunha F.Q., and Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. USA 102 (2005) 1755-1760
12. DeLeo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. The Neuroscientist 10 (2004) 40-52
13. Dhabhar F.S. Stress-induced augmentation of immune function - The role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun. 16 (2002) 785-798
14. Dhabhar F.S., and McEwen B.S. Acute stress enhances while chronic stress suppresses immune function in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 11 (1997) 286-306
15. Dhabhar F.S., and McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA 96 (1999) 1059-1064
16. Dhabhar F.S., McEwen B.S., and Spencer R.L. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels-a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res. 616 (1993) 89-98
17. Dhabhar F.S., Miller A.H., McEwen B.S., and Spencer R.L. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J. Immunol. 154 (1995) 5511-5527
18. Dhabhar F.S., Miller A.H., McEwen B.S., and Spencer R.L. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J. Immunol. 157 (1996) 1638-1644
19. Di Rosa M., Giroud J.P., and Willoughby D.A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol. 104 (1971) 15-29
20. Dixon W.J. Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 20 (1980) 441-462
21. Doolittle R.F. The origins and evolution of eukaryotic proteins. Phil. Trans. Royal Soc. London Biol. Sci. 349 (1995) 235-240
22. El-Chemaly S., Salathe M., Baier S., Conner G.E., and Forteza R. Hydrogen peroxide-scavenging properties of normal human airway secretions. Am. J. Respir. Crit. Care Med. 167 (2003) 425-430
23. Elmer G.I., Pieper J.O., Negus S.S., and Woods J.H. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75 (1998) 129-140
24. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277 (1996) 633-645
25. Fecho K., Nackley A.G., Wu Y., and Maixner W. Basal and Carrageenan-induced pain behavior in Sprague-Dawley, Lewis and Fisher rats. Physiol. Behav. 85 (2005) 177-186
26. Ferreira S.H., Lorenzetti B.B., Bristow A.F., and Poole S. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 (1988) 698-699
27. Ferreira S.H., Lorenzetti B.B., and Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110 (1993) 1227-1231
28. Ferrick M.R., Thurau S.R., Oppenheim M.H., Herbort C.P., Ni M., Zachariae C.O.C., Matsushima K., and Chan C.C. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest. Ophthalmol. Vis. Sci. 32 (1991) 1534-1539
29. Goodnow C.C., Sprent J., Fazekas de St. Groth B., and Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435 (2005) 590-597
30. 15N]nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
31. Happ M.P., Wettstein P., Dietzschold B., and Heber-Katz E. Genetic control of the development of experimental allergic encephalomyelitis in rats: separation of MHC and non-MHC gene effects. J. Immunol. 141 (1988) 1489-1494
32. Handy R.L.C., and Moore P.K. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br. J. Pharmacol. 123 (1998) 1119-1126
33. Hargreaves K., Dubner R.;, Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32 (1988) 77-88
34. Herradón G., Ezquerra L., Moralis L., Franklin B., Silos-Santiago I., and Alguacil L.F. Lewis and Fischer 344 strain differences in α2-adrenoceptors and tyrosine hydroxylase expression. Life Sci. 78 (2006) 862-868
35. 2-adrenoceptor and opioid receptor mechanisms to antinociception differs in Lewis and Fischer 344 rats. Eur. J. Pharmacol. 465 (2003) 251-256
36. Holtman Jr. J.R., and Wala E.P. Characterization of morphine-induced hyperalgesia in male and female rats. Pain 114 (2005) 62-70
37. Hylden J.L., Thomas D.A., Iadarola M.J., Nahin R.L., and Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194 (1991) 135-143
38. Karalis K., Crofford L., Wilder R.L., and Chrousos G.P. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology 136 (1995) 3107-3112
39. Kasama T., Miwa Y., Isozaki T., Odai T., Adachi M., and Kunkel S.L. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy 4 (2005) 273-279
40. Kayser V., and Guilbaud G. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats. Brain Res. 267 (1983) 131-138
41. Kiefer F., and Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict. Biol. 9 (2004) 205-212
42. Kleinbaum D.G., Kupper L.L., Muller K.E., and Nizam A. Dummy variables in regression. Applied Regression Analysis and Other Multivariable Methods. third ed. (1998), Duxbury Press at Brooks/Cole Publishing Co, Pacific Grove, CA 317-360
43. Kosten T.A., and Ambrosio E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27 (2002) 35-69
44. Leung B.P., Culshaw S., Gracie J.A., Hunter D., Canetti C.A., Campbell C., Cunha F., Liew F.Y., and McInnes I.A. A role for IL-18 in neutrophil activation. J. Immunology 167 (2001) 2879-2886
45. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100 (2002) 213-217
46. Martin S., Manzanares J., Corchero J., Garcia-Lecumberri C., Crespo J.A., Fuentes J.A., and Ambrosio E. Differential basal proenkephalin gene expression in dorsal striatum and nucleus accumbens, and vulnerability to morphine self-administration in Fischer 344 and Lewis rats. Brain Res. 821 (1999) 350-355
47. Mason D., MacPhee I., and Antoini F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 7 (1990) 1-5
48. Mellon R.D., and Bayer B.M. Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J. Neuroimmunol. 83 (1998) 19-28
49. Misiewicz B., Poltorak M., Raybourne R.B., Gomez M., Listwak S., and Sternber E.M. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation. Exp. Neurol. 146 (1997) 305-314
50. Mogil J.S., Kest B., Sadowski B., and Belknap J.K. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J. Pharmacol. Exp. Ther. 276 (1996) 532-544
51. Mogil J.S. Complex trait genetics of pain in the laboratory mouse. In: Mogil J.S. (Ed). The Genetics of Pain (2004), IASP Press, Seattle, WA 123-149
52. Ossipov M.H., Lai J., Vanderah T.W., and Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci. 73 (2003) 783-800
53. Pechnick R.N. Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu. Rev. Pharmacol. Toxicol. 32 (1993) 353-382
54. Peers S.H., Duncan G.S., and Flower R.J. Development of specific antibody and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosteroids. Agents Actions 39 (1993) 174-181
55. Perretti M., Duncan G.S., Flower R.J., and Peers S.H. Serum corticosterone, interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strains. Br. J. Pharmacol. 110 (1993) 868-874
56. 2 receptors, tumor necrosis factor α and inflammatory hyperalgesia. Br. J. Pharmacol. 126 (1999) 649-656
57. Riad M., Mogos M., Thangathurai D., and Lumb P.D. Steroids. Curr. Opin. Crit. Care 8 (2002) 281-284
58. Ribeiro R.A., Vale M.L., Ferreira S.H., and Cunha F.Q. Analgesic effect of thalidomide on inflammatory pain. Eur. J. Pharmacol. 391 (2000) 97-103
59. Rivest S., and Rivier C. Stress and interleukin-1 beta-induced activation of c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: comparison between Sprague-Dawley, Fisher-344 and Lewis rats. J. Neuroendocrinol. 6 (1994) 101-117
60. Sampson A.P. The role of eosinophils and neutrophils in inflammation. Clin. Exp. Allergy 30 Suppl. 1 (2000) 22-27
61. Segal A.W. How neutrophils kill microbes. Annu. Rev. Immunol. 23 (2005) 197-223
62. Simonnet G., and Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain?. NeuroReport 14 (2003) 1-7
63. Stanfa L.C., and Dickenson A.H. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation. Br. J. Pharmacol. 108 (1993) 967-973
64. Stein C., Millan M.J., Yassouridis A., and Herz A. Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism. Eur. J. Pharmacol. 155 (1988) 255-264
65. Sternberg E.M., Young III W.S., Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., and Wilder R.L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86 (1989) 4771-4775
66. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., and Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci.USA 86 (1989) 2374-2378
67. Sternberg E.M., Glowa J.R., Smith M.A., Calogero A.E., Listwak S.J., Aksentijevich S., Chrousos G.P., Wilder R.L., and Gold P.W. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res. 570 (1992) 54-60
68. Straub R.H., Dhabhar F.S., Bijlsma J.W.J., and Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthr. Rheum. 52 (2005) 16-26
69. 5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices. Eur. J. Pharmacol. 229 (1992) 1-7
70. Suarez-Roca H., and Maixner W. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264 (1993) 648-653
71. Suarez-Roca H., and Maixner W. Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons. Neurosci. Lett. 194 (1995) 41-44
72. Tonelli L., Webster J.I., Rapp K.L., and Sternberg E. Neuroendocrine responses regulating susceptibility and resistance to autoimmune/inflammatory disease in inbred rat strains. Immunol. Rev. 184 (2001) 203-211
73. Tsuji R.F., Hoshino K., Noro Y., Tsuji N.M., Kurokawa R., Masuda T., Akira S., and Nowak B. Suppression of allergic reaction by λ-carrageenan: toll-like receptor 4/MyD88-dependent and-independent modulation of immunity. Clin. Exp. Allergy 33 (2003) 249-258
74. Vaccarino A.L., and Couret Jr. L.C. Relationship between hypothalamic-pituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: a strain comparison. Pain 63 (1995) 385-389
75. Vajja B.N.L., Jului S., Kumari M., Kole L., Chakrabarti R., and Joshi V.D. Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents. Int. Immunol. 4 (2004) 901-909
76. Vallejo R., de Leon-Casasola O., and Benyamin R. Opioid therapy and immunosuppression: a review. Am. J. Ther. 11 (2004) 354-365
77. Vinegar R., Schreiber W., and Hugo R. Biphasic development of carrageenin edema in rats. J. Pharmacol. Exp. Ther. 166 (1969) 96-103
78. Walker A., Ward C., Taylor E.L., Dransfield I., Hart S.P., Haslett C., and Rossi A.G. Regulation of neutrophil apoptosis and removal of apoptotic cells. Curr. Drug Targets Inflamm. Allergy 4 (2005) 447-454
79. Wei R., and Sternberg E.M. IL-1 beta-mediated neuropeptide and immediate early gene mRNA induction is defective in Lewis hypothalamic cell cultures. J. Neuroimmunol. 146 (2004) 114-125
80. Wei R., Phillips T.M., and Sternberg E.M. Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. J. Neuroimmunol. 131 (2002) 31-40
81. Wei R., Listwak S.J., and Sternberg E.M. Lewis hypothalamic cells constitutively and upon stimulation express higher levels of mRNA for pro-inflammatory cytokines and related molecules: comparison with inflammatory resistant Fischer rat hypothalamic cells. J. Neuroimmunol. 135 (2003) 10-28
82. Wei X., Charles I.G., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Moncada S., and Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408-411
83. G-monomethyl-l-arginine. J. Exp. Med. 179 (1994) 651-660
84. Wilder R.L., Calandra G.B., Garvin A.J., Wright K.D., and Hansen C.T. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthr. Rheum. 25 (1982) 1064-1072
85. Wilson S.G., Smith S.B., Chesler E.J., Melton K.A., Haas J.J., Mitton B., Strasburg K., Hubert L., Rodriguez-Zas S.L., and Mogil J.S. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically-distinct analgesics. J. Pharmacol. Exp. Ther. 304 (2003) 547-559
86. Winter C.A., Risley E.A., and Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547